Actinium Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK, INC. | 02/07/2025 | 1.97 M | $2.48 M | 1.73% | 6.35% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 687,853 | $866,838 | 0.25% | 2.21% |
STATE STREET CORP | 02/14/2025 | 621,075 | $782,555 | 3.06% | 2.00% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 499,260 | $628,000 | 10.04% | 1.61% |
NORTHERN TRUST CORP | 02/14/2025 | 251,930 | $317,431 | 4.92% | 0.81% |
LOS ANGELES CAPITAL MANAGEMENT LLC | 02/04/2025 | 213,950 | $269,577 | 24.99% | 0.69% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 190,400 | $239,904 | 49.92% | 0.61% |
SQUAREPOINT OPS LLC | 02/14/2025 | 183,262 | $230,910 | 25.43% | 0.59% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 117,454 | $147,992 | -26.65% | 0.38% |
CREATIVE FINANCIAL DESIGNS INC /ADV | 02/10/2025 | 91,007 | $114,669 | 42.68% | 0.29% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 78,767 | $99,247 | 76.64% | 0.25% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 75,700 | $95,382 | -1.69% | 0.24% |
RHUMBLINE ADVISERS | 01/30/2025 | 40,720 | $51,298 | 4.42% | 0.13% |
XTX TOPCO LTD | 02/13/2025 | 25,606 | $32,264 | -82.03% | 0.08% |
CITIGROUP INC | 02/12/2025 | 25,308 | $31,888 | 16.36% | 0.08% |
VONTOBEL HOLDING LTD. | 01/30/2025 | 25,000 | $31,500 | 100.00% | 0.08% |
PFG INVESTMENTS, LLC | 01/22/2025 | 18,250 | $22,995 | 100.00% | 0.06% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 17,073 | $21,512 | 4.66% | 0.05% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 15,635 | $19,700 | -2.74% | 0.05% |
AM INVESTMENT STRATEGIES LLC | 01/21/2025 | 14,422 | $18,000 | 0.00% | 0.05% |
INTECH INVESTMENT MANAGEMENT LLC | 02/11/2025 | 14,198 | $17,889 | 100.00% | 0.05% |
INTREPID FINANCIAL PLANNING GROUP LLC | 02/10/2025 | 14,000 | $17,640 | -26.32% | 0.05% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 13,890 | $17,501 | 0.00% | 0.04% |
PROSPECT FINANCIAL SERVICES LLC | 01/22/2025 | 12,400 | $15,624 | 100.00% | 0.04% |
02/14/2025 | 10,831 | $13,647 | 100.00% | 0.03% | |
NORTH STAR ASSET MANAGEMENT INC | 02/19/2025 | 10,000 | $12,600 | 100.00% | 0.03% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 9,547 | $12,029 | 140.00% | 0.03% |
02/11/2025 | 7,915 | $9,973 | 100.00% | 0.03% | |
PICTON MAHONEY ASSET MANAGEMENT | 04/02/2025 | 5,968 | $7,000 | 100.00% | 0.02% |
FMR LLC | 02/13/2025 | 4,740 | $5,972 | -44.31% | 0.02% |
LEGAL & GENERAL GROUP PLC | 02/13/2025 | 3,713 | $4,678 | 0.00% | 0.01% |
FEDERATED HERMES, INC. | 02/13/2025 | 2,743 | $3,456 | 37.15% | 0.01% |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/06/2025 | 2,000 | $2,520 | 0.00% | 0.01% |
NISA INVESTMENT ADVISORS, LLC | 01/17/2025 | 1,338 | $1,686 | 476.72% | 0.00% |
01/31/2025 | 1,000 | $1,260 | 100.00% | 0.00% | |
AMALGAMATED BANK | 02/04/2025 | 877 | $1,000 | 0.00% | 0.00% |
NATIONAL BANK OF CANADA /FI/ | 02/12/2025 | 855 | $1,077 | 0.00% | 0.00% |
02/06/2025 | 542 | $683 | 100.00% | 0.00% | |
BFSG, LLC | 01/31/2025 | 500 | $630 | 0.00% | 0.00% |
HARTFORD FINANCIAL MANAGEMENT INC. | 01/23/2025 | 266 | $336 | 0.00% | 0.00% |
EVERSOURCE WEALTH ADVISORS, LLC | 02/10/2025 | 74 | $93 | 100.00% | 0.00% |
STERLING CAPITAL MANAGEMENT LLC | 02/13/2025 | 31 | $39 | 0.00% | 0.00% |
BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
ROYCE & ASSOCIATES LP | 02/10/2025 | 0 | $0 | -100.00% | 0.00% |
MARSHALL WACE, LLP | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
VERITION FUND MANAGEMENT LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
VIRTU FINANCIAL LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
SRS CAPITAL ADVISORS, INC. | 02/05/2025 | 0 | $0 | -100.00% | 0.00% |
MAN GROUP PLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Actinium Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 62 institutional investors and hedge funds held shares of Actinium Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 1.97 M
GEODE CAPITAL MANAGEMENT, LLC: 687,853
STATE STREET CORP: 621,075
ACADIAN ASSET MANAGEMENT LLC: 499,260
NORTHERN TRUST CORP: 251,930
LOS ANGELES CAPITAL MANAGEMENT LLC: 213,950
26.18% of Actinium Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 8.27 M shares in the last 24 months. This purchase volume represents approximately $10.38 M in transactions.